| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | fentanyl (Opiodur®) |
| Formulation | 12 micrograms/hour, 25 micrograms/hour, 50 micrograms/hour, 75 micrograms/hour and 100 micrograms/hour transdermal patch |
| Reference number | 2397 |
| Indication | Use in adults in severe chronic pain which can be adequately managed only with opioid analgesics. Long term management of severe chronic pain in children receiving opioid therapy from 2 years of age |
| Company | Pfizer Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 10/01/2014 |